Case number 2018-1422
Merck Sharp & Dohme Corp. v. Actavis Laboratories FL, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 3, 2018 | 20 | ORDER filed. The stay of the briefing schedule is lifted.; The motion [19] is granted. The appeal is dismissed.; Each side shall bear its own costs.; ISSUED AS A MANDATE: May 3, 2018. Service: 05/03/2018 by clerk. [518718] [NL] [Entered: 05/03/2018 10:27 AM] (2) |
| Apr 26, 2018 | 19 | MOTION of Joint Stipulation of Voluntary Dismissal of Appeal Appellants Actavis Laboratories FL, Inc., Actavis Pharma, Inc. and Andrx Corporation to voluntarily dismiss appeal pursuant to FRAP 42(b). [Consent: unopposed]. Service: 04/26/2018 by email. [517191] [18-1422] [Linnea Cipriano] [Entered: 04/26/2018 05:41 PM] (3) |
| Apr 20, 2018 | 18 | ORDER filed. The motion to remand [17] is granted to the limited extent explained in the order. The court retains jurisdiction over the appeal at this time.; Proceedings in this appeal are stayed pending the district court’s ruling on the motion to enter amendment to final judgment. Within seven days from the date of the district court’s ruling on the motion, the parties are directed to inform this court how they believe this appeal should proceed. Service: 04/20/2018 by clerk. [515565] [NL] [Entered: 04/20/2018 10:43 AM] (2) |
| Mar 29, 2018 | 17 | MOTION of Appellee Merck Sharp & Dohme Corp. and Appellants Andrx Corporation, Actavis Laboratories FL, Inc. and Actavis Pharma, Inc. for limited remand. Any response is due within 10 days of service. [Consent: unopposed]. Service: 03/29/2018 by email. [509242] [18-1422] [Linnea Cipriano] [Entered: 03/29/2018 03:13 PM] (16) |
| Mar 15, 2018 | 16 | ORDER granting motion to extend time to file appellant's principal brief [15] filed by Appellants Andrx Corporation, Actavis Pharma, Inc. and Actavis Laboratories FL, Inc.. Brief is due 05/21/2018. Service as of this date by the Clerk of Court. [505626] [CMP] [Entered: 03/15/2018 03:24 PM] (2) |
| Mar 12, 2018 | 15 | MOTION of Appellants Actavis Laboratories FL, Inc., Actavis Pharma, Inc. and Andrx Corporation to extend the time to 05/21/2018 at 11:59 pm to file the appellant/petitioner's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 03/12/2018 by email. [504272] [Elizabeth Holland] [Entered: 03/12/2018 03:28 PM] (6) |
| Feb 2, 2018 | 14 | CORRECTED certificate of service for Appellee Merck Sharp & Dohme Corp. for attorney entry of appearance , Doc No. [2], attorney entry of appearance , Doc No. [5], attorney entry of appearance , Doc No. [6]. Service: 02/01/2018 by email. [494684] [David Greenwald] [Entered: 02/02/2018 10:30 AM] (1) |
| Feb 1, 2018 | 2 | Entry of appearance for David Greenwald as principal counsel for Appellee Merck Sharp & Dohme Corp.. Service: 02/01/2018 by email. [494500] [David Greenwald] [Entered: 02/01/2018 03:54 PM] (1) |
| Feb 1, 2018 | 3 | Docketing Statement for the Appellee Merck Sharp & Dohme Corp.. Service: 02/01/2018 by email. [494503] [David Greenwald] [Entered: 02/01/2018 03:56 PM] (3) |
| Feb 1, 2018 | 4 | Certificate of Interest for the Appellee Merck Sharp & Dohme Corp.. Service: 02/01/2018 by email. [494506] [David Greenwald] [Entered: 02/01/2018 03:57 PM] (3) |
| Feb 1, 2018 | 5 | Entry of appearance for Evan R. Chesler as of counsel for Appellee Merck Sharp & Dohme Corp.. Service: 02/01/2018 by email. [494511] [Evan Chesler] [Entered: 02/01/2018 04:00 PM] (1) |
| Feb 1, 2018 | 6 | Entry of appearance for Samira Shah as of counsel for Appellee Merck Sharp & Dohme Corp.. Service: 02/01/2018 by email. [494516] [Samira Shah] [Entered: 02/01/2018 04:03 PM] (1) |
| Feb 1, 2018 | 7 | Entry of appearance for Huiya Wu as of counsel for Appellants Actavis Laboratories FL, Inc., Actavis Pharma, Inc. and Andrx Corporation. Service: 02/01/2018 by email. [494544] [Huiya Wu] [Entered: 02/01/2018 05:08 PM] (1) |
| Feb 1, 2018 | 8 | Entry of appearance for Linnea P. Cipriano as of counsel for Appellants Actavis Laboratories FL, Inc., Actavis Pharma, Inc. and Andrx Corporation. Service: 02/01/2018 by email. [494547] [Linnea Cipriano] [Entered: 02/01/2018 05:11 PM] (1) |
| Feb 1, 2018 | 9 | Entry of appearance for Robert V. Cerwinski as of counsel for Appellants Actavis Laboratories FL, Inc., Actavis Pharma, Inc. and Andrx Corporation. Service: 02/01/2018 by email. [494550] [Robert Cerwinski] [Entered: 02/01/2018 05:14 PM] (1) |
| Feb 1, 2018 | 10 | Entry of appearance for William M. Jay as of counsel for Appellants Actavis Laboratories FL, Inc., Actavis Pharma, Inc. and Andrx Corporation. Service: 02/01/2018 by email. [494551] [William Jay] [Entered: 02/01/2018 05:18 PM] (1) |
| Feb 1, 2018 | 11 | Entry of appearance for Elizabeth J. Holland as principal counsel for Appellants Actavis Laboratories FL, Inc., Actavis Pharma, Inc. and Andrx Corporation. Service: 02/01/2018 by email. [494552] [Elizabeth Holland] [Entered: 02/01/2018 05:21 PM] (1) |
| Feb 1, 2018 | 12 | Certificate of Interest for the Appellants Actavis Laboratories FL, Inc., Actavis Pharma, Inc. and Andrx Corporation. Service: 02/01/2018 by email. [494555] [Elizabeth Holland] [Entered: 02/01/2018 05:23 PM] (2) |
| Feb 1, 2018 | 13 | Docketing Statement for the Appellants Actavis Laboratories FL, Inc., Actavis Pharma, Inc. and Andrx Corporation. Service: 02/01/2018 by email. [494556] [Elizabeth Holland] [Entered: 02/01/2018 05:25 PM] (4) |
| Jan 18, 2018 | 1 | Appeal docketed. Received: 01/12/2018. [490581]Entry of Appearance due 02/01/2018. Certificate of Interest is due on 02/01/2018. Docketing Statement due 02/01/2018. Appellants' brief is due 03/19/2018. [CMP] [Entered: 01/18/2018 09:18 AM] (29) |
